Morgan Stanley Sticks to Their Sell Rating for Petmed Express (PETS)
Morgan Stanley Maintains PetMed Express(PETS.US) With Sell Rating, Maintains Target Price $3.5
Analysts Offer Insights on Healthcare Companies: Petmed Express (PETS), Myomo (MYO) and Accuray (ARAY)
Morgan Stanley Reaffirms Their Sell Rating on Petmed Express (PETS)
PetMed Express Analyst Ratings
Lake Street Downgrades PetMed Express to Hold, Lowers Price Target to $3.5
Petmed Express: Hold Rating With Cautious Outlook Amidst Management Changes and Competitive Challenges
Lake Street Maintains Buy on PetMed Express, Lowers Price Target to $7
PetMed Express Analyst Ratings
Morgan Stanley Lowers Price Target on PetMed Express to $3.50 From $6.50, Maintains Underweight Rating
Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), MiMedx Group (MDXG) and Petmed Express (PETS)
Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)
Analysts Offer Insights on Healthcare Companies: Petmed Express (PETS), Dynatronics (DYNT) and Silk Road Medical (SILK)
PetMed Express Analyst Ratings
Morgan Stanley Trims Price Target on PetMed Express to $6.50 From $7, Keeps Underweight Rating
Petmed Express (PETS) Gets a Buy From Lake Street
PetMed Express Analyst Ratings
Morgan Stanley Cuts Price Target on PetMed Express to $7 From $10 After Fiscal Q2 Miss, Keeps Underweight Rating
PetMed Express Analyst Ratings
Morgan Stanley Reiterates Underweight on PetMed Express, Maintains $17 Price Target